Membrane Interactions and Toxicity by Misfolded Protein Oligomers. by Gonzalez-Garcia, Mario et al.
fcell-09-642623 March 5, 2021 Time: 15:56 # 1
REVIEW




University of Malta, Malta
Reviewed by:
John H. Viles,
Queen Mary University of London,
United Kingdom
Carmelo La Rosa,





This article was submitted to
Molecular Medicine,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 16 December 2020
Accepted: 08 February 2021
Published: 11 March 2021
Citation:
Gonzalez-Garcia M, Fusco G and
De Simone A (2021) Membrane
Interactions and Toxicity by Misfolded
Protein Oligomers.
Front. Cell Dev. Biol. 9:642623.
doi: 10.3389/fcell.2021.642623
Membrane Interactions and Toxicity
by Misfolded Protein Oligomers
Mario Gonzalez-Garcia1, Giuliana Fusco2 and Alfonso De Simone1,3*
1 Department of Life Sciences, Imperial College London, South Kensington, United Kingdom, 2 Department of Chemistry,
Centre for Misfolding Diseases, University of Cambridge, Cambridge, United Kingdom, 3 Department of Pharmacy, University
of Naples Federico II, Naples, Italy
The conversion of otherwise soluble proteins into insoluble amyloid aggregates is
associated with a range of neurodegenerative disorders, including Alzheimer’s and
Parkinson’s diseases, as well as non-neuropathic conditions such as type II diabetes and
systemic amyloidoses. It is increasingly evident that the most pernicious species among
those forming during protein aggregation are small prefibrillar oligomers. In this review,
we describe the recent progress in the characterization of the cellular and molecular
interactions by toxic misfolded protein oligomers. A fundamental interaction by these
aggregates involves biological membranes, resulting in two major model mechanisms
at the onset of the cellular toxicity. These include the membrane disruption model,
resulting in calcium imbalance, mitochondrial dysfunction and intracellular reactive
oxygen species, and the direct interaction with membrane proteins, leading to the
alteration of their native function. A key challenge remains in the characterization of
transient interactions involving heterogeneous protein aggregates. Solving this task is
crucial in the quest of identifying suitable therapeutic approaches to suppress the cellular
toxicity in protein misfolding diseases.
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INTRODUCTION
The misfolding and aggregation of otherwise functional proteins is linked with a number of
neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), as
well as non-neuropathic conditions such as type II diabetes (T2D) and systemic amyloidoses.
The protein fibrils forming in association with these pathologies share common properties such
as a core rich in β-sheet structure adopting a characteristic cross-β topology, the resistance to
degradation and significant mechanical properties with tensile strength that is similar to steel.
The precursor proteins involved in protein misfolding diseases (PMDs), however, are considerably
different in their native states and range from disordered proteins (e.g., amyloid-beta – Aβ – in AD,
α-synuclein – αSyn – in PD, the prion protein in prion disease) to structured monomers (e.g., beta-
2 microglobulin – β2m – in β2m-amyloidosis) or globular oligomers (the transthyretin – TTR –
tetramer in TTR-amyloidosis). The structural similarity between the mature amyloid aggregates has
suggested the existence of some generic mechanism of toxicity. One of the recursive mechanisms
includes the impairment of clearance control processes that suppress protein aggregation and
toxicity in the cell, which is likely coupled with the higher prevalence of these conditions in
aging populations. A detailed understanding of the molecular origins of PMDs is, however,
missing, including the balance between loss of function of native proteins or gain in toxicity by
aberrant aggregates.
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In this review, we summarize the state of the art in the study
of the mechanisms of toxicity associated with aberrant protein
aggregation, with a specific focus on the interaction between
protein oligomers and biological membranes, a central step at the
onset and development of PMDs.
TOXICITY OF PROTEIN OLIGOMERS
It is now recognized that the most toxic species in the etiology of
PMDs are the small and diffusible prefibrillar oligomers forming
during protein aggregation or released by mature fibrils (Hartl,
2017). Protein oligomers have been shown to induce higher levels
of cellular toxicity than mature fibrils. This has been consistently
observed in many protein systems including Aβ (Walsh et al.,
2002) and tau (Ward Sarah et al., 2012) in AD, αSyn (Winner
et al., 2011) in PD and human islet amyloid polypeptide (IAPP)
in type II diabetes (Abedini et al., 2016; Scollo and La Rosa, 2020).
Compared to mature fibrils, protein oligomers have specific
molecular structural characteristics that enhance their ability to
induce neurotoxicity, including small size (Mannini et al., 2014),
exposure of hydrophobic surfaces (Vivoli Vega et al., 2019) and
unsaturated edge-strands (De Simone et al., 2008). The transient
and heterogeneous nature of these species, however, makes it
elusive to study their properties in vitro or in vivo. Recent
investigations have been successful in identifying some of the
key properties at the origin of the cellular toxicity by misfolded
protein oligomers, including the disruption of the mitochondrial
function (Westermark et al., 2011; Ghio et al., 2019), the
induction of increased levels of basal calcium (Angelova et al.,
2016), the generation of metal dyshomeostasis (Angelova et al.,
2016) and stimulation of reactive oxygen species (Cheignon
et al., 2018). A central role in most of these mechanisms of
toxicity is the interaction between misfolded protein oligomers
and biological membranes, including plasma and mitochondrial
membranes (Figure 1), which will be overviewed here with
respect to two major models, namely the membrane disruption
and receptor-mediated interaction.
DISRUPTION OF BIOLOGICAL
MEMBRANES BY TOXIC PROTEIN
OLIGOMERS
Oligomers in PMDs have been shown to disrupt a variety of
cellular processes, including alterations of the calcium signaling
(Quist et al., 2005; Kim et al., 2018) due to the disruption
of the plasma membrane (Lin et al., 2001; Angelova et al.,
2016). Several molecular mechanisms have been identified for
the plasma membrane permeabilization by various types of
misfolded protein oligomers (Figure 2). In the case of αSyn,
oligomers are believed to disrupt the neuronal membrane by
binding the lipid bilayer via the N-terminal region of the
protein and by inserting their core into its hydrophobic interior
(Fusco et al., 2017). This mechanism favors fluxes through the
neuronal membrane of small ions and larger molecules such
as the calcein dye (Cascella et al., 2019). By directly targeting
the lipophilic region of the oligomers using antibodies, the
toxicity of αSyn aggregates is suppressed, as shown in vitro
and C. elegans (Cascella et al., 2019). The permeabilization of
the plasma membrane upon interaction with protein oligomers
has also been shown by electrophysiology studies of membrane
conductance (Feng et al., 2010). These observations are consistent
with the formation of pores of different dimensions in the
membrane upon treatment with oligomers (Wong Su et al., 2018),
as observed using atomic force microscopy (Chaudhary et al.,
2016; Oropesa-Nuñez et al., 2016; Bode et al., 2019). The ability
to generate these pores has been associated to the exposure of
hydrophobic regions (Vivoli Vega et al., 2019) and the size of the
protein oligomers (Mannini et al., 2014; Chiti and Dobson, 2017).
Another model is based on evidence supporting the formation
of ion channels by protein oligomers at the origin of the
pathophysiology for amyloid diseases. Aβ42 has been shown to
form discrete pore structures ranging between 1.7 and 2.4 nm in
diameter (Bode et al., 2017). The architecture and dimensions of
these pores resemble annular Aβ oligomers that had previously
been shown to form tetrameric and hexameric channel-like
structures by atomic force microscopy (Lin et al., 2001; Quist
et al., 2005; Jang et al., 2010), which were also shown to generate
discrete current bursts. Similar channel-like structures have been
reported for αSyn (Lashuel et al., 2002; Kayed et al., 2009;
Chen et al., 2015) having ion channel-like activity (Kim et al.,
2009; Tosatto et al., 2012). These findings suggest an additional
common mechanism of alteration of ion homeostasis in the
pathogenesis of PMDs.
The membrane interaction by misfolded protein oligomers
is also strongly influenced by the lipid composition, which is a
modulator of the downstream cellular toxicity. An increase in the
content of gangliosides and cholesterol in the cellular membrane
enhances the toxicity of misfolded oligomers of the HypF-N
protein model system in vitro (Evangelisti et al., 2012). This is
consistent with evidence of a correlation between age-related
alterations of the lipid homeostasis and neurodegenerative
diseases, as well as with altered fractions of gangliosides in
brains of Alzheimer’s patients (Yamamoto et al., 2008), including
membrane fractions from the frontal cortex and the temporal
cortex (Molander-Melin et al., 2005) as well as in lipid rafts
(Liu et al., 2015a).
Neurodegenerative conditions also feature lipid peroxidation
due to oxidative stress, which has been shown to enhance protein
misfolding and aggregation as well as to promote membrane
permeability (Liu et al., 2008; Choi and Gandhi, 2018; Michalska
and León, 2020). This generates a positive feedback mechanism in
which the peroxidation of the membrane triggers more vigorous
protein aggregation, as shown for Aβ (Pilkington et al., 2019)
and αSyn (Angelova et al., 2020a), which in turn generates
additional oligomers, thereby enhancing the oxidative stress and
lipid peroxidation. Products of lipid peroxidation have been
found in brains of both PD and AD patients, as well as in
animal models of such diseases (Joshi et al., 2006; Picklo and
Montine, 2007; Dalfó and Ferrer, 2008; Padurariu et al., 2010).
Peroxidation leads to defects in the packing of the phospholipids
and weakens cellular membranes, making them more vulnerable
to pore formation induced by protein aggregates. Oxidative stress
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FIGURE 1 | Aberrant interactions between misfolded protein aggregates and biological membranes. Toxic protein oligomers can bind strongly biological
membranes, including plasma and mitochondrial membranes, as well as membrane proteins. Perturbation and pore formation (A) of the lipid bilayer by misfolded
protein aggregates may generate membrane disruption and ultimately its permeabilization (B), leading to aberrant processes such as mitochondrial dysfunction,
intracellular ROS and release of cytochrome c. In addition, interactions of misfolded protein aggregates with membrane receptors (C,D) and mitochondrial receptors
(E) result in loss of function (e.g., VDACs, α3-NKA) or overactivation (e.g., mGluRs, NMDARs), with consequent alteration of the cellular viability, including calcium
gradient imbalance and cellular and organelle dysfunction. Indeed, most of the interactions of misfolded protein aggregates with cellular membranes and membrane
proteins have a common downstream effect on the Ca2+-dependent toxicity. In this scheme, interactions and processes by protein oligomers at the surface of
biological membranes are shown. (A) Pore formation. (B) Membrane permeabilization. (C) Interaction with Ionotropic/metabotropic glutamate receptors.
(D) Interaction with plasma membrane receptors (e.g., α7 nAChR, α3-NKA, etc.). (E) Mitochondrial receptors interactions (VDACs, mPTP, etc.). (F) Intracellular ROS
production. Protein aggregates are schematically shown in purple, Ca2 + ions in orange and neurotransmitter molecules in blue.
also alters the chemical integrity of proteins, which is also a
way to promote aggregation of amyloidogenic proteins (Angelova
et al., 2020b), leading to a feed-forward loop where aberrant
interactions with membranes are intensified.
It has also been proposed that complexes between misfolded
proteins and free lipids in solution would be at the origin of
membrane disruption in PMDs (lipid-chaperone hypothesis).
The model suggests that pre-binding to lipids would favor the
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FIGURE 2 | Disruption of biological membranes by misfolded protein oligomers. A variety of mechanisms of membrane disruption by misfolded protein oligomers
were proposed including (A) partial insertion of the oligomers into the hydrophobic region of the membrane, (B) pore formation, (C) membrane thinning and
redistribution of lipids through a detergent-like mechanism (Sciacca et al., 2018). The consequent loss of membrane integrity results in aberrant Ca2+ influx, the
generation of ROS and the alteration of signaling pathways, ultimately inducing cell death in a Ca2+-dependent manner. (D) In the mitochondria, preferential binding
to cardiolipin (depicted as yellow lipids) by misfolded protein oligomers promotes aberrant protein-membrane interactions. Defects in the mitochondrial membranes
lead to ionic gradient imbalances, which in turn interrupt the electron transport chain and compromise the process of mitochondrial respiration. A defective
mitochondrial electron transport chain, in association with elevated Ca2+ influx result in an increase in intracellular ROS. The loss of mitochondrial membrane
potential signals the release of cytochrome c.
insertion of oligomers into the membrane in a chaperone-
like mechanism (La Rosa et al., 2016; Scollo et al., 2018;
Sciacca et al., 2020).
MITOCHONDRIAL MEMBRANE
DISRUPTION
Oxidative phosphorylation in the mitochondria is responsible
for most of the energy required for normal cellular function,
a process that is particularly relevant for neuronal cells where
a significant energetic consumption is required for synaptic
transmission (Attwell and Laughlin, 2001). The mitochondrial
dysfunction has been associated to most PMDs (Cenini et al.,
2019), and evidence exists for a role of misfolded protein
oligomers in the impairment of the mitochondrial function.
Post-mortem brains of PD and AD patients indeed revealed
the co-localization of aggregates of Aβ, αSyn and tau with
mitochondrial membranes (Hsu et al., 2000) and mitochondrial-
associated membranes (Guardia-Laguarta et al., 2014). In vitro
and animal studies have shown that prefibrillar oligomers
induce neuronal death following mitochondrial membrane
damage and mitochondrial dysfunction (Lashuel, 2005; Glabe,
2006; Cenini et al., 2019; Farrugia et al., 2020; Figure 2).
Misfolded protein oligomers from tau, Aβ, IAPP, and αSyn have
generally high affinity for the lipid composition of mitochondria,
and particularly for their cardiolipin component (Camilleri
et al., 2013, 2020; Kegulian et al., 2015; Ghio et al., 2019).
Cardiolipin is a fundamental phospholipid that is exclusively
found in mitochondrial membranes, where it plays a crucial
role in many biochemical processes, including respiration and
signaling. The characteristic structure of cardiolipin, which is
formed by two phosphatidyl residues and four acyl chains
joined by a glycerol bridge, has a profound effect on the
curvature and packing of mitochondrial membranes (Horvath
and Daum, 2013) and promotes the binding of protein oligomers
(Elías-Wolff et al., 2019).
In the pathophysiology of PD, mitochondrial dysfunction is
a strong element inducing neuronal impairment. Transmission
electron microscopy analysis of dopaminergic neurons
overexpressing wild-type αSyn demonstrated abnormal
mitochondrial morphologies, including fragmentation and
malformed cristae (Ganjam et al., 2019). Indeed, several
mutations in genes responsible for mitochondrial and reactive
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oxygen species (ROS) homeostasis (PINK1, PINK2 (Parkin),
LRRK2, and DJ-1) have been shown to lead to PD (Bonifati
et al., 2002; Valente et al., 2004; Gilks et al., 2005; Nichols et al.,
2005). In vitro incubation of αSyn with isolated mitochondria
(Ghio et al., 2019) results in the formation of membrane pores
in a cardiolipin-dependent manner. Amounting evidence has
demonstrated the accumulation of αSyn specifically on the
internal mitochondrial membrane (IMM) (Devi et al., 2008),
which is rich in cardiolipin (20% of total lipids) compared to the
outer mitochondrial membrane [OMM (5% of lipid content)]
(Klingenberg, 2009; Horvath and Daum, 2013; Pariary et al.,
2019). Prefibrillar αSyn oligomers have been shown to trigger an
unregulated influx of Ca2+, leading to mitochondrial calcium
overload in isolated mitochondria and in dopaminergic neuronal
models (Luth et al., 2014; Angelova et al., 2016). This induced
the opening of the mitochondrial permeability transition pore
(mPTP) (Luth et al., 2014), triggering the depolarization of
the mitochondria (Sherer et al., 2002; Banerjee et al., 2010;
Nakamura, 2013) and the release of cytochrome c (Hsu et al.,
2000; Devi et al., 2008; Luth et al., 2014), leading in turn to the
activation of cytoplasmic caspases signaling for a downstream
apoptotic response (Ganjam et al., 2019).
Consistent with these findings, tau oligomers, but not
monomers or fibrils, were able to disrupt model mitochondrial
membranes in a cardiolipin-dependent manner (Camilleri et al.,
2020), whereas the ability of tau to inhibit calcium efflux from the
mitochondria was shown to induce mitochondrial depolarization
in cortical neurons with consequent calcium-induced caspase
3 activation (Britti et al., 2020). Emerging evidence reported
the perturbation of the mitochondrial membranes by Aβ42
oligomers (Glabe, 2006; Reddy, 2009; Camilleri et al., 2013; Oren
et al., 2020) resulting in the impairment of calcium homeostasis,
the reduction in the activity of respiratory chain complex I and IV
(Mutisya et al., 1994; Casley et al., 2002; Rhein et al., 2009), and
the induction of apoptotic pathways (Resende et al., 2008; Umeda
et al., 2011; Bhat et al., 2015).
In the context of amyotrophic lateral sclerosis (ALS),
aggregates of superoxide dismutase 1 (SOD1) have been
associated with widespread mitochondrial dysfunction and
mitochondrial membrane perturbation, as mitochondrial defects
have been observed in tissues from ALS patients (Hirano
et al., 1984). SOD1 aggregates were observed to bind the
cytoplasmic leaflet of the OMM (Deng et al., 2006; Lin
and Beal, 2006) and localize with mitochondria in a tissue-
dependent manner (Vande Velde et al., 2008). Mitochondrial
dysfunction as a result of membrane integrity defects caused
by misfolded SOD1 has been reported in vitro in neuronal
cells (Carrì et al., 1997; Menzies et al., 2002) and in vivo in
mutant SOD1 transgenic rodent models (Higgins et al., 2002;
Mattiazzi et al., 2002), as well as in ALS patients (Swerdlow
et al., 1998; Wiedemann et al., 2002). Moreover, in vitro
incubation of SOD1 oligomers and fibrils was observed to lead
to the permeabilization of the membranes of isolated rat brain
mitochondria (Oladzad Abbasabadi et al., 2013).
Perturbation of mitochondrial membranes is also found
in non-neuropathic amyloidoses, including lysozyme systemic
amyloidosis, T2D and type I diabetes (T1D) (Gurlo et al., 2010;
Westermark et al., 2011, 2017). IAPP aggregates, associated
with the pathology of T2D, have been shown to perturb
mitochondrial membranes and accumulate at mitochondrial
cristae (Kegulian et al., 2015). Membrane-associated IAPP
oligomers have also been shown to have a general ability
to permeate the plasma membrane through the formation
of small and large pores, of which only the latter were
considered cytotoxic (Pannuzzo et al., 2013; Birol et al., 2018).
Indeed, mitochondrial membrane depolarization downstream
of membrane damage (Birol et al., 2018) has been associated
with cellular dysfunction and apoptosis in T2D (Gurlo et al.,
2010). Whether disruption of the mitochondrial membranes
is the initial step, or a major amplifier in the process of cell
death leading to loss of β-cells in the pancreas during the
development of diabetes, remains unclear. Similarly, perturbation
of mitochondrial membranes by prefibrillar oligomers but not
monomers or fibrils of hen egg white lysozyme has been observed
in vitro using isolated rat brain mitochondria (Meratan et al.,
2011; Meratan and Nemat-Gorgani, 2012), with membrane
defects causing the release of mitochondrial enzymes and
cytochrome c (Meratan et al., 2011).
RECEPTOR-MEDIATED TOXICITY BY
PROTEIN OLIGOMERS
In addition to promoting loss of membrane integrity, misfolded
protein aggregates have been proposed to induce toxicity via
direct interaction with membrane proteins (Figure 3). The
“receptor-mediated model” of toxicity of misfolded protein
oligomers involves a plethora of membrane proteins and
results in the transduction of deleterious signals and ultimately
cellular toxicity.
The glutamate receptor family – metabotropic glutamate
receptors (mGluR), N-methyl-D-aspartate receptors (NMDAR)
and AMPA receptors (AMPAR) – has emerged as a key target
for the intracellular transduction of toxic signals by misfolded
proteins. The metabotropic glutamate mGluR5 receptors are
amongst the major receptors for Aβ aggregates, as their co-
localization has been repeatedly reported (Casley et al., 2009;
Lim et al., 2013; Shrivastava et al., 2013). Indeed, knockout of
mGluR5s results in a reduction in neurodegeneration induced
by Aβ oligomers (Hamilton et al., 2014). Trapping of mGluR5s
receptors by Aβ aggregates results in the increased localization
of the glutamate receptors at excitatory synapses and dendritic
spines, generating a constitutively active signaling complex
that leads to an increased mGluR5s-dependent intracellular
Ca2+ signal (Renner et al., 2010). In the presence of Aβ
oligomers, mGlu5Rs mediate the excessive release of Ca2+ from
the endoplasmic reticulum (ER) in neurons and consequently
lead to cellular toxicity (Renner et al., 2010; Um et al.,
2013). Indeed, upregulation of mGlu5Rs has been observed in
brains of PD patients, suggesting a putative role for mGlu5Rs
receptors in protein oligomer pathology in PD (Sanchez-
Pernaute et al., 2008; Price et al., 2010; Morin et al., 2013).
In general, an increased expression of mGlu5Rs seen in AD,
PD and other neurodegenerative diseases results in an elevated
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FIGURE 3 | Aberrant interactions of misfolded protein oligomers with membrane receptors. Misfolded protein oligomers are able to bind a variety of proteins on the
plasma and mitochondrial membranes, resulting in the alteration of their functions. These interactions may result in overactivation and hence gain-of-function (e.g.,
mGluR5s or NMDARs) whereas internalization (e.g., AMPARs, α7 AChR) and clustering of transporters (e.g., α3-NKA) may lead to loss-of-function. The binding to
the receptors has been shown to alter the ionic gradients and generate an excess of intracellular and mitochondrial Ca2+. The resulting opening of the mPTP causes
the depolarization of the mitochondria, which triggers the release of cytochrome c and consequent signaling for apoptosis. Disruption of the electron transport chain
by direct binding of oligomers to the respiratory complexes exacerbates the calcium-mediated toxicity through the unregulated generation of ROS. In this schematic
figure, interactions with (A) ionotropic/metabotropic glutamate receptors, (B) nicotinic receptors (e.g., NKA transporter) and (C) mitochondrial receptors (e.g.,
TOM20), are shown in association with (D) the resulting ROS generation.
availability of mGlu5Rs at the synapses, which is likely to
be responsible for the observed rise in intracellular Ca2+
and consequent calpain activation, ER stress and cell death
(Mattson, 2007).
Oligomeric Aβ may also contribute to neurotoxicity through
the overactivation of the ionotropic glutamate receptor NMDA,
which is involved in synaptic plasticity stimulation, memory,
learning and the assembly of neuronal connections (Li and Tsien,
2009). By interfering with the function of NMDA receptors,
Aβ oligomers trigger an abnormal influx of Ca2+ into neurons,
which can lead to excitotoxicity (Alberdi et al., 2010; Liang
et al., 2017). Aβ oligomers also stimulate the internalization
of AMPA receptors in a calcineurin-dependent manner (Hsieh
et al., 2006), resulting in receptor depletion from the postsynaptic
surface, as well as trafficking of AMPAR to the membrane upon
synaptic potentiation (Rui et al., 2010). Additionally, the potential
coupling of NMDA receptors with other synaptic receptors such
as α3-NKA and mGlu5Rs, could compromise the physiological
function of NMDA, thereby impairing long-term potentiation
(LTP) (Hu et al., 2014).
The association between Aβ and the cellular prion protein
(PrPC) has recently attracted a large attention. PrPC has
putatively high affinity for Aβ oligomers and has been suggested
to induce neurotoxic processes through the mediation of Aβ
toxicity (Laurén et al., 2009; Salazar et al., 2017; Brody and
Strittmatter, 2018; Purro et al., 2018; Zhang et al., 2019), leading
to the impairment of synaptic plasticity and defects in LTP in
AD (Freir et al., 2011). Acting as an extracellular platform with
the ability to coordinate multiprotein interactions, PrPC has been
proposed to mediate downstream signaling intracellularly from
the cell surface upon Aβ binding (e.g., mGluR5, α7 AChR) (Um
et al., 2013; Haas et al., 2014, 2016; Hu et al., 2014; Zhang et al.,
2019). Specifically, the interaction between Aβ and PrPC has
been implicated in dendritic spine loss through the activation
of the Fyn kinase, and the consequent phosphorylation of the
NR2B subunit of the NMDA receptor (Um et al., 2012; Brody
and Strittmatter, 2018). Downstream of Fyn activation is the
tyrosine kinase Pyk, which has been shown to phosphorylate
tau (Li and Götz, 2018), a step associated with AD (Iqbal et al.,
2010). Furthermore, the Aβ/PrPC interaction can recruit the low-
density lipoprotein receptor-related protein-1 (LRP1) to facilitate
the cell internalization of Aβ aggregates (Rushworth et al., 2013).
LRP1 has also been implicated in tau endocytosis and spread
(Rauch et al., 2020), and may therefore potentially control the
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internalization of both toxic forms of tau and Aβ in AD. More
generally, PrPC has been described as a mediator of the toxicity of
a number of misfolded proteins involved in neurodegeneration.
αSyn and tau have been shown to bind immobilized PrP, on
mouse cortical neurons and in vivo (Ferreira et al., 2017; Corbett
et al., 2020). In addition, the interaction between αSyn and PrPC
appears to induce aberrant Ca2+ levels and synaptic deficits in
an mGluR5-mediated manner involving activation of the NMDA
receptor (Ferreira et al., 2017).
In addition to a gain of function of membrane receptors,
the interaction with protein aggregates may also result in loss
of function, as in the case of the α3-Na+/K+ ATPase (α3-
NKA) sodium pump upon binding with Aβ and αSyn aggregates
(Ohnishi et al., 2015; Shrivastava et al., 2015). The activity of
the NKA transporter is strongly associated with the brain energy
consumption, leading to the possibility that its impairment may
be involved in an energy crisis in the brain (Shrivastava et al.,
2017). Aβ oligomers have been shown to impair the NKA
catalytic activity, whilst αSyn has been shown to compromise the
ability of this transporter to readily export sodium ions as a result
of co-clustering around synapses. Additionally, a recent study
demonstrated the ability of mutant SOD1 to interact also with
α3-NKA in ALS (Ruegsegger et al., 2016).
Misfolded protein oligomers have also been observed to
interact with mitochondrial membrane proteins. Voltage-
dependent anion channels (VDACs) in the mitochondrial outer
membrane have been reported to play a role in the toxicity
associated with protein misfolding. It has been proposed that
VDAC may allow the entry of αSyn into mitochondria (Lu et al.,
2013), whereas other studies suggested that αSyn induces loss
of function of VDAC in vitro in a voltage-dependent manner,
leading to a reduction in the levels of ATP and ADP that
compromise mitochondrial respiration (Rostovtseva et al., 2015).
In the context of ALS, aggregates of mutant variants of SOD1
have been observed to accumulate on the OMM through direct
interactions with VDAC1 (Israelson et al., 2010) and Bcl-2
(Pedrini et al., 2010), causing VDAC dysfunction leading to
altered membrane potential, morphology and protein trafficking
in mitochondria. Binding of mutant but not wild-type SOD1 to
Bcl-2 induces a conformational change that uncovers its BH3
(death) domain. These processes lead to an increase in the
affinity of Bcl-2 for VDAC, which in turn triggers the closure
of the channel (Tan et al., 2013) and ultimately the activation
of mitochondrial apoptosis. These steps appear to contribute to
the initiation and development of motor neuron loss in ALS
(Tafuri et al., 2015).
In the context of Huntington’s disease (HD), mutant
huntingtin (Htt) has been associated with the opening of mPTP
in the inner mitochondrial membrane, triggering the release
of cytochrome c and activating apoptosis (Choo et al., 2004).
Moreover, changes in mitochondrial membrane potential are
mediated by abnormal high levels of intracellular Ca2+ as a
result of an excessive release of calcium from the ER following
the interaction between Htt and the InsP3 receptor (IP3R)
as well as an increased influx upon NMDAR overstimulation
(Damiano et al., 2010). The latter is mediated by polyglutamine-
expanded Htt through disruption of the physiological interaction
between normal Htt and PSD95, a scaffold protein associated
with NMDA-receptor function (Sun et al., 2001; Song et al., 2003).
The overactivation of NMDA-receptors may indeed be a key
factor in the etiology of HD, in what is known as the excitotoxicity
hypothesis that postulates that neuronal degeneration in HD
results from a hyperactivation of glutamate receptors following
an abnormal glutamatergic neurotransmission (DiFiglia, 1990).
Injection of NMDA agonists into the striatum of rats induced
indeed the degeneration of GABAergic neurons in a pattern
reminiscent of the pathology of HD (Brouillet et al., 1999).
Alzheimer’s disease is also associated with impairment of the
cholinergic pathway in the cerebral cortex and basal forebrain,
which involves two main classes of receptors, muscarinic
(mAChR) and nicotinic acetylcholine receptors (nAChR) (Sarter
and Paolone, 2011; Maurer and Williams, 2017). A decrease in
the number of nAChRs in AD results from the loss of forebrain
cholinergic neurons and a cholinergic presynaptic denervation
(Hampel et al., 2018). It has been postulated that under
physiological conditions, Aβ42 may enhance synaptic plasticity
and memory through the stimulation of α7 nAChR (Puzzo et al.,
2015). Under pathological conditions, however, accumulation
of aggregates of Aβ would lead to the internalization and
impairment of α7 AChR in a negative feedback loop, ultimately
resulting in synaptic alteration and loss of memory. Evidence
suggests that the complex formed between Aβ and α7 nAChR
would be able to induce tau hyperphosphorylation (Wang et al.,
2003) and promote plaque formation (Nagele et al., 2003; Dineley
et al., 2007), which are both hallmarks of AD. In order to
compensate for the internalization of the Aβ-α7 nAChR complex,
α7 nAChR is upregulated (Shen and Wu, 2015) with further
internalization of the complex leading to the accumulation of
Aβ, the overwhelming of the lysosomes and ultimately neuronal
lysis (Palop and Mucke, 2010). In addition to an Aβ-dependent
internalization of α7 nAChR, upregulation of α7 nAChR in
the membrane may result in elevated Ca2 + influx, further
contributing to neurotoxicity (Liu et al., 2015b). Interestingly,
administration of α7 nAChR antagonists to rats rescued learning
deficits associated with overactivation of the receptors (Burke
et al., 2014), hinting at a possible therapeutic opportunity for
overstimulated α7 nAChRs in AD.
CONCLUSION
In summary, there is growing evidence about the key relevance
of the membrane interaction by misfolded protein oligomers
in PMDs. Two principal mechanisms, namely the membrane
disruption and the receptor binding, are supported by extensive
experimental evidence. It remains, however, difficult to identify
the dominant mechanism of toxicity in PMDs, primarily owing
to the heterogeneous and transient nature of misfolded protein
oligomers. These species have the ability to interact with a
variety of cellular membranes and membrane proteins, with
affinities that can be modulated by several factors, including the
properties of the membrane (Chaudhary et al., 2016; Oropesa-
Nuñez et al., 2016; Bode et al., 2019) and the lipid composition
(Evangelisti et al., 2012; Sciacca et al., 2020). The level of
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biological complexity associated with these processes, therefore,
poses tremendous challenges in the quest of identifying effective
therapeutic strategies to suppress the cellular toxicity in PMDs,
as these conditions are associated with various imbalances in
cellular homeostasis, and their initiation or propagation can be
triggered by multiple concurring factors.
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